Bildkälla: Stockfoto

Speqta Q4’21 Review: Bidbrain in Focus – Strategic Revision Continues - Redeye

Redeye retains its positive view on Speqta, currently trading below net cash. We leave our Base Case unchanged, awaiting the revised strategy and management’s capital allocation plans.

Redeye retains its positive view on Speqta, currently trading below net cash. We leave our Base Case unchanged, awaiting the revised strategy and management’s capital allocation plans.
Börsvärldens nyhetsbrev
ANNONSER